AUNA
AunaAUNA
AUNA
About: Auna SA is a healthcare provider. It operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru, and dental and vision plans in Mexico. Its network includes several healthcare network facilities, consisting of hospitals, outpatient, prevention, and wellness facilities. The company operates in the following segments; Oncosalud Peru and Healthcare services in Peru, Columbia and Mexico. Key revenue is generated from Peru.
Employees: 14,842
0
Funds holding %
of 7,407 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
12% more funds holding
Funds holding: 17 [Q3] → 19 (+2) [Q4]
0.62% less ownership
Funds ownership: 14.88% [Q3] → 14.26% (-0.62%) [Q4]
5% less capital invested
Capital invested by funds: $30.9M [Q3] → $29.4M (-$1.5M) [Q4]
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$13.50
94%
upside
Avg. target
$13.50
94%
upside
High target
$13.50
94%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
JP Morgan Joseph Giordano 24% 1-year accuracy 6 / 25 met price target | 94%upside $13.50 | Overweight Maintained | 11 Feb 2025 |
Financial journalist opinion
Based on 3 articles about AUNA published over the past 30 days
Neutral
Business Wire
1 week ago
Auna Announces the Filing of Its Form 20-F for the Fiscal Year 2024
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”) (NYSE: AUNA), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2024, with the Securities and Exchange Commission (the “SEC”) on April 10, 2025. Auna's Annual Report on Form 20-F can be accessed by visiting either the SEC's website at www.sec.gov or the “Financial Info” section of the Company's Invest.
Positive
Seeking Alpha
1 week ago
Auna: Strong Q4, Execution In Mexico Will Be Key, Reiterating Buy
Auna achieved strong 2024 results with 11% revenue growth and 20% EBITDA growth, driven by successful operations in Peru and expansion efforts in Mexico. Mexico's market potential is significant, with strategic partnerships and a focus on oncologic plans, while Colombia faces regulatory challenges impacting profitability. The company is focused on deleveraging, aiming for a leverage ratio below 3X by 2025, driven by a projected 20% EBITDA growth.
Negative
Zacks Investment Research
3 weeks ago
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?
Here is how Auna S.A. (AUNA) and Coya Therapeutics, Inc. (COYA) have performed compared to their sector so far this year.
Neutral
Business Wire
1 month ago
Auna Announces 4Q24 and FY 2024 Financial Results
LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the fourth quarter ended December 31, 2024 (“fourth quarter 2024” or “4Q24”) and full year ended 2024 (“full-year 2024” or “FY24”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unles.
Neutral
Business Wire
1 month ago
Auna Signs Exclusive Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey
MONTERREY, Mexico--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician group practicing at Organización Para Cuidado Integral en Oncología, S.A. de C.V. known as Opción Oncología, the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna's commitment to becoming the leading oncolo.
Positive
Zacks Investment Research
1 month ago
Is Auna S.A. (AUNA) Stock Outpacing Its Medical Peers This Year?
Here is how Auna S.A. (AUNA) and BioMarin Pharmaceutical (BMRN) have performed compared to their sector so far this year.
Positive
Zacks Investment Research
2 months ago
Wall Street Analysts Predict a 39.33% Upside in Auna S.A. (AUNA): Here's What You Should Know
The mean of analysts' price targets for Auna S.A. (AUNA) points to a 39.3% upside in the stock.
Negative
Zacks Investment Research
2 months ago
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?
Here is how Auna S.A. (AUNA) and BioNTech SE Sponsored ADR (BNTX) have performed compared to their sector so far this year.
Positive
Seeking Alpha
2 months ago
Stock Picks From Seeking Alpha's January 2025 New Analysts
In January, Seeking Alpha welcomed 29 new analysts. This article introduces them and showcases some of their top picks. Analysts highlighted include The Conservative Investor recommending Dassault Aviation, Christopher Gray on ASML Holding, and Inflexio Research on Bragg Gaming Group, all rated as Buys. Analysts' diverse backgrounds span sectors like technology, finance, and consumer staples, with investment strategies focusing on value, growth, and special situations.
Neutral
Business Wire
2 months ago
Auna Announces Reporting Dates for Fourth Quarter and Full-Year 2024 Financial Results
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2024 financial results. Earnings Release Monday, March 10, 2025 Time: After Market Close Conference Call Tuesday, March 11, 2025 Time: 8:00 a.m. ET Quiet Period Monday, February 17 through Monday, March 10, 2025 To participate, please dia.
Charts implemented using Lightweight Charts™